Department of Neurosurgery, Tianjin Institute of Neurology, Tianjin Medical University General Hospital, 154 Anshan Road in Heping District, Tianjin, 300052, China.
Department of Neurosurgery, The First Affiliated Hospital of Nanchang University, Nanchang, China.
Eur Spine J. 2023 Apr;32(4):1326-1333. doi: 10.1007/s00586-023-07585-9. Epub 2023 Feb 25.
Clinical outcome of spinal cavernous malformation (SCM) varies because of its unclear natural history, and reliable prognostic prediction model for SCM patients is limited. The aim of the present study was to investigate potential factors that predict one-year neurological status in postoperative patients with SCM.
This was a multicenter prospective observational study in consecutive patients with SCMs. SCMs treated microsurgically between January 2015 and January 2021 were included. Outcome was defined as the American Spinal Injury Association Impairment Scale (AIS) grade at one year after operation. Multivariable analyses were used to construct the best predictive model for patient outcomes.
We identified 268 eligible SCM patients. Neurological outcome had worsened from preoperative baseline in 51 patients (19.0%) at one year. In the multivariable logistic regression, the best predictive model for unfavorable outcome included symptom duration ≥ 26 months (95% CI 2.80-16.96, P < 0.001), size ≤ 5 mm (95% CI 1.43-13.50, P = 0.010), complete intramedullary (95% CI 1.69-8.14, P = 0.001), subarachnoid hemorrhage (95% CI 2.92-12.57, P < 0.001), AIS B (95% CI 1.91-40.93, P = 0.005) and AIS C (95% CI 1.12-14.54, P = 0.033).
Admission size of the lesion, morphology, symptom duration, AIS grade and the presence of subarachnoid hemorrhage were strong outcome predictors regarding prognostication of neurological outcome in postoperative patients with SCMs. A decision to surgically remove a symptomatic SCM should be justified by systematic analysis of all factors potentially affecting outcome.
由于脊髓海绵状血管畸形(SCM)的自然病史不明确,其临床转归存在差异,目前可靠的 SCM 患者预后预测模型有限。本研究旨在探讨预测 SCM 患者术后 1 年神经状态的潜在因素。
这是一项多中心前瞻性观察性研究,纳入了连续的 SCM 患者。纳入 2015 年 1 月至 2021 年 1 月期间接受显微镜下治疗的 SCM 患者。术后 1 年的结局定义为美国脊柱损伤协会损伤分级(AIS)。采用多变量分析构建患者结局的最佳预测模型。
我们共纳入 268 例符合条件的 SCM 患者。术后 1 年,51 例(19.0%)患者的神经功能较术前基线恶化。多变量逻辑回归分析显示,预后不良的最佳预测模型包括症状持续时间≥26 个月(95%CI:2.80-16.96,P<0.001)、病变最大直径≤5mm(95%CI:1.43-13.50,P=0.010)、完全脊髓内(95%CI:1.69-8.14,P=0.001)、蛛网膜下腔出血(95%CI:2.92-12.57,P<0.001)、AIS B 级(95%CI:1.91-40.93,P=0.005)和 AIS C 级(95%CI:1.12-14.54,P=0.033)。
病变的初始大小、形态、症状持续时间、AIS 分级和蛛网膜下腔出血的存在是预测 SCM 术后患者神经功能预后的有力因素。决定对有症状的 SCM 进行手术切除时,应系统分析所有可能影响结局的因素。